Publication

Santa Fe BioLabs is granted patent for Candida auris detection

613 cases of Candida auris per recent tracking information released by the Center for Disease Control, April 30, 2019

New York state has reported over 400 cases of Candida auris infection in the past few years

April 12, 2019

Candida auris: Why it is a superbug and why it is so hard to kill, April 10, 2019

Santa Fe BioLabs test for Candida auris

Surge of Candida auris in LA county due to COVID

Deadly Fungus Spread Rapidly During the Pandemic, New York Times article, March 2019

Santa Fe BioLabs concludes development of Candida auris culturing and detection products and is awarded wide-ranging patent for designing differential microbial media

Santa Fe BioLabs investment portfolio includes Zylö Therapeutics, Ayuvis and VenoStent

Recent publication by Santa Fe BioLabs in J. Analytical Oncology 9, 33-45

Fort Worth Star Telegram: Candida auris a concern in Tarrant County

News

Associated Press: Climate change may be a factor in Candida auris pandemic

Analysis of CDC data by

Santa Fe BioLabs